Lyso‐phosphatidylinositol (LPI) is generated by PLA2 and a G protein receptor 55 (GPR55), upregulated in human cSCC and suggested to promote skin carcinogenesis and tumor aggressiveness.37 The gene discussed is GPR55; the disease is neoplasm.